(Reuters) - Medical device maker Boston Scientific Corp (BSX.N) said it will buy Endo International Plc's (ENDP.O) American Medical Systems' men's and prostate health business for up to $1.65 billion.
The purchase ends a nearly decade-long deal drought for Boston Scientific, which has not completed a large takeover since its 2006 acquisition of heart device maker Guidant Corp for $27 billion.
21:06 Apple's Q4 2016 results: Better than expected with 45.5 million iPhones sold, but revenue continues to slide16
12:23 Lockheed Martin's quarterly profit handily beats estimates13
11:46 GM reports record 3Q earnings despite slowing US sales8
11:07 Procter & Gamble earnings: $1.03 a share, vs 98 cents expected15